# Moderna partners with OpenAI to accelerate the development of life-saving treatments

## Метаданные

- **Канал:** OpenAI
- **YouTube:** https://www.youtube.com/watch?v=t3UHnKLVS1M
- **Дата:** 24.04.2024
- **Длительность:** 2:50
- **Просмотры:** 67,735

## Описание

Moderna deployed ChatGPT Enterprise to thousands of employees, seeing remarkable adoption across the company. They’ve created hundreds of custom versions of ChatGPT, including a pilot Dose ID GPT that uses the advanced data analysis feature to further evaluate and verify the optimal vaccine dose selected by the clinical study team.

Learn more about Moderna’s work with ChatGPT: https://openai.com/customer-stories/moderna

## Содержание

### [0:00](https://www.youtube.com/watch?v=t3UHnKLVS1M) Segment 1 (00:00 - 02:00)

We Believe very profoundly at Mona that chat GPT and what open air is doing is going to change the world we already looking at every business process from legal to research to manufacturing to Commercial and to think about how would you redesign those processes with uh chpt type tools 90% of companies want to go do gen but only 10% of them are successful they haven't built the mechanisms of actually transforming your Workforce to adopt new technology and new capabilities we've been born as a platform company and we think about our drug development as a platform and with the onset of Enterprise chat GPT these gpts became embedded into the workflows of how our users are really using it we're up to now 400 gpts within 2 months uh far more than what we expect Ed some might be surprised that the legal department was the first Department to wholly adopt chat GPT here at madna we have a 100% adoption rate of chat GPT and other generative AI large language models here in the company one of the gpts that we're most excited about is called contract companion you can upload the contract into the GPT ask it for a quick highlevel summary or even ask specific questions and what it enables the legal function to do is to focus our time and attention on those matters that are truly driving an impact for patients to allow us to deliver on our mission here at M dose ID GPT really allows us to take these large data sets of thousands of pages and input that into the GPT it makes an optimal dose recommendation from thousands of pages of data it provides supportive rationale for why we're picking a specific dose over other doses it allows us to create customized visualization so we can really understand the data and it also allows the study team members to have a conversation with the GPT to analyze the data from multiple different angles I think we're very lucky as a company because you know we're going to launch 15 products in the next 5 years but if you think about it if we had to do it the old biopharmaceutical ways we might need 100,000 people today company is less than 6,000 people we really believe we can maximize our impact on patient with a few thousand people for using technology and using AI so we can scale the company and so I'm very thankful for the entire openi team and the time and engagement they have with our team so that together we can save more lives

---
*Источник: https://ekstraktznaniy.ru/video/11549*